4.6 Article

YAP is a candidate oncogene for esophageal squamous cell carcinoma

Journal

CARCINOGENESIS
Volume 32, Issue 3, Pages 389-398

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/carcin/bgq254

Keywords

-

Categories

Funding

  1. Global Center of Excellence Program [4201]
  2. Ministry of 520 Education, Culture, Sports, Science, and Technology, Japan
  3. Ministry of Health, Labor and Welfare, Japan
  4. Japan Science and Technology Corporation
  5. New Energy and Industrial Technology Development Organization
  6. Grants-in-Aid for Scientific Research [4201, 22240090, 22134002, 21790267] Funding Source: KAKEN

Ask authors/readers for more resources

Yes-associated protein (YAP), the nuclear effector of the Hippo pathway, is a key regulator of organ size and a candidate human oncogene located at chromosome 11q22. Since we previously reported amplification of 11q22 region in esophageal squamous cell carcinoma (ESCC), in this study we focused on the clinical significance and biological functions of YAP in this tumor. Frequent overexpression of YAP protein was observed in ESCC cells including those with a robust amplicon at position 11q22. Overexpression of the YAP protein was frequently detected in primary tumors of ESCC as well. Patients with YAP-overexpressing tumors had a worse overall rate of survival than those with non-expressing tumors, and YAP positivity was independently associated with a worse outcome in the multivariate analysis. Further analyses in cells in which YAP was either overexpressed or depleted confirmed that cell proliferation was promoted in a YAP isoform-independent but YAP expression level-dependent manner. YAP depletion inhibited cell proliferation mainly in the G(0)-G(1) phase and induced an increase in CDKN1A/p21 transcription but a decrease in BIRC5/survivin transcription. Our results indicate that YAP is a putative oncogene in ESCC and it represents a potential diagnostic and therapeutic target.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available